OlegCTcheremissineMD

PubMed

• 8 citations
  The Impact of Once-Monthly Paliperidone Palmitate on Healthcare Utilization Among Patients With Schizophrenia Treated in an Integrated Healthcare System: A Retrospecti...
  Rohan Mahabaleshwarkar, Dee Lin, Jesse Fishman, Todd Blair, Timothy Hetherington, Pooja Palmer, Charmi Patel, Carmela Benson, Kruti Joshi, Constance Krull, Oleg V Tche...> ;Advances in Therapy. 2021 Mar 11
• 2 citations
  Development of a Behavioral Health Stigma Measure and Application of Machine Learning for Classification.
  Farah Tokmic, Mirsad Hadzikadic, James R. Cook, Oleg V. Tcheremissine> ;Innovations in Clinical Neuroscience. 2018 Jun 1
• 6 citations
  Modafinil Augmentation Therapy in Patient with Traumatic Brain Injury.
  Oleg V Tcheremissine, James Rachal> ;Innovations in Clinical Neuroscience. 2017 Mar 1
• 2 citations
  Gabapentin Abuse in a Patient with Comorbid Mood and Substance Use Disorders.
  Oleg V Tcheremissine, Durga Bestha> ;Innovations in Clinical Neuroscience. 2016 Jul 1
• Conducting clinical research in community mental health settings: Opportunities and challenges
  Oleg V Tcheremissine, Whitney Rossman, Manuel A Castro, Dineen R Gardner> ;World Journal of Psychiatry. 2014 Sep 22
• 1 citations
  A case of paranoid schizophrenia and severe antipsychotic-induced Parkinson's disorder treated with a combination of olanzapine and lurasidone.
  Oleg V Tcheremissine, Danielle Englert> ;Innovations in Clinical Neuroscience. 2013 Sep 1
• 5 citations
  Targeting cognitive deficits in schizophrenia: a review of the development of a new class of medicines from the perspective of community mental health researchers
  Oleg V Tcheremissine, Manuel A Castro, Dineen R Gardner> ;Expert Opinion on Investigational Drugs. 2012 Jan 1
• 1 citations
  Once-daily medications for the pharmacological management of ADHD in adults
  Oleg v Tcheremissine, Lori M. Lieving> ;Therapeutics and Clinical Risk Management. 2009 May 11
• 15 citations
  Is quetiapine a drug of abuse? Reexamining the issue of addiction
  Oleg V Tcheremissine> ;Expert Opinion on Drug Safety. 2008 Nov 4
• 8 citations
  Pharmacotherapy of adult attention deficit/hyperactivity disorder: review of evidence-based practices and future directions.
  Oleg v Tcheremissine, J Octavio Salazar> ;Expert Opinion on Pharmacotherapy. 2008 May 12
• 12 citations
  Pharmacological aspects of the treatment of conduct disorder in children and adolescents
  Oleg V. Tcheremissine, Lori M. Lieving> ;CNS Drugs. 2006 Jan 1
• 4 citations
  Individual differences in aggressive responding to intravenous flumazenil administration in adult male parolees.
  Oleg V. Tcheremissine, Scott D. Lane, Lori M. Lieving, Howard M. Rhoades, Sylvain O. Nouvion, Don R. Cherek> ;Journal of Psychopharmacology. 2005 Nov 1
• 1 citations
  Pharmacotherapy of postpartum depression: current practice and future directions.
  Oleg V Tcheremissine, Lori M. Lieving> ;Expert Opinion on Pharmacotherapy. 2005 Oct 3
• 2 citations
  Psychopharmacology of conduct disorder: current progress and future directions
  Oleg V. Tcheremissine, Don R. Cherek, Scott D. Lane> ;Expert Opinion on Pharmacotherapy. 2004 May 1
• Join now to see all